Michael R Abern

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint The characteristics of bladder cancer after radiotherapy for prostate cancer
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA Electronic address
    Urol Oncol 31:1628-34. 2013
  2. doi request reprint Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database
    Michael R Abern
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27705, USA
    Prostate 73:409-17. 2013
  3. doi request reprint Characteristics and outcomes of tumors arising from the distal nephron
    Michael R Abern
    Division of Urologic Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Urology 80:140-6. 2012
  4. ncbi request reprint Characteristics of patients diagnosed with both melanoma and renal cell cancer
    Michael R Abern
    Division of Urology, Department of Surgery, Duke Cancer Institute, Duke University Medical Center, 200 Trent Drive, DUMC Box 2804, Durham, NC, 27710, USA
    Cancer Causes Control 24:1925-33. 2013
  5. ncbi request reprint Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml
    Peter Qi
    Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Urol Oncol 31:1527-32. 2013
  6. ncbi request reprint Radiation exposure associated with dedicated renal mass computed tomography protocol: impact of patient characteristics
    Matvey Tsivian
    Division of Urology, Department of Surgery, Duke University Medical Center, Duke Cancer Institute, Durham, North Carolina 27713, USA
    J Endourol 27:1102-6. 2013
  7. ncbi request reprint Evolution of the concept of focal therapy for prostate cancer
    Matvey Tsivian
    Division of Urology, Department of Surgery, Duke University Medical Center, Duke Cancer Institute, Durham, North Carolina, USA
    Oncology (Williston Park) 27:64-8, 70; discussion 70. 2013
  8. ncbi request reprint Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria
    Michael R Abern
    Division of Urologic Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Curr Urol Rep 13:160-9. 2012
  9. ncbi request reprint Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, North Carolina, USA
    J Natl Compr Canc Netw 11:477-84. 2013
  10. pmc Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer
    Richmond A Owusu
    Division of Urology, Duke University Medical Center, Box 2812, Durham, NC 27710, USA
    Biomed Res Int 2013:262313. 2013

Detail Information

Publications13

  1. ncbi request reprint The characteristics of bladder cancer after radiotherapy for prostate cancer
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, NC 27710, USA Electronic address
    Urol Oncol 31:1628-34. 2013
    ..While irradiated patients have adverse surgical outcomes, how RT affects survival is also unknown. We sought to determine how RT for prostate cancer (CaP) affects the characteristics and outcomes of secondary CaB...
  2. doi request reprint Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database
    Michael R Abern
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27705, USA
    Prostate 73:409-17. 2013
    ..It is unknown whether delaying radical prostatectomy (RP) is associated with increased risk of biochemical recurrence (BCR) for men with intermediate-risk PC...
  3. doi request reprint Characteristics and outcomes of tumors arising from the distal nephron
    Michael R Abern
    Division of Urologic Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Urology 80:140-6. 2012
    ..To compare the characteristics and predictors of cancer-specific survival (CSS) of 2 rare distal nephron tumors--medullary renal cell carcinoma (MRCC) and collecting duct carcinoma (CDC)...
  4. ncbi request reprint Characteristics of patients diagnosed with both melanoma and renal cell cancer
    Michael R Abern
    Division of Urology, Department of Surgery, Duke Cancer Institute, Duke University Medical Center, 200 Trent Drive, DUMC Box 2804, Durham, NC, 27710, USA
    Cancer Causes Control 24:1925-33. 2013
    ..Patients with renal cell carcinoma (RCC) and malignant melanoma (MM) have an increased risk of additional malignancies. We identified characteristics of MM and RCC associated with a patient developing both cancers...
  5. ncbi request reprint Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml
    Peter Qi
    Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Urol Oncol 31:1527-32. 2013
    ..This study aimed to evaluate long-term oncological outcomes of patients undergoing RP with preoperative PSA <2.5 and 2.5-4 ng/ml compared with PSA 4.1-10 ng/ml...
  6. ncbi request reprint Radiation exposure associated with dedicated renal mass computed tomography protocol: impact of patient characteristics
    Matvey Tsivian
    Division of Urology, Department of Surgery, Duke University Medical Center, Duke Cancer Institute, Durham, North Carolina 27713, USA
    J Endourol 27:1102-6. 2013
    ..We sought to quantify the effective dose associated with RMP-CT and to determine how patient factors affect radiation exposure...
  7. ncbi request reprint Evolution of the concept of focal therapy for prostate cancer
    Matvey Tsivian
    Division of Urology, Department of Surgery, Duke University Medical Center, Duke Cancer Institute, Durham, North Carolina, USA
    Oncology (Williston Park) 27:64-8, 70; discussion 70. 2013
    ..Here we focus on the evolution of the concept of focal therapy and its potential roles in the management of prostate cancer...
  8. ncbi request reprint Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria
    Michael R Abern
    Division of Urologic Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Curr Urol Rep 13:160-9. 2012
    ..In addition, the recent literature regarding technological advances in prostate biopsy and imaging strategies are added to the current guidelines to recommend a rationale for patient selection...
  9. ncbi request reprint Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, North Carolina, USA
    J Natl Compr Canc Netw 11:477-84. 2013
    ..A single dose of IVC administered within 24 hours of TUR of NMIBC was found to result in a reduction in tumor recurrence (RR, 0.67; 95% CI, 0.56-0.79). Patients with higher-risk tumor features seem to benefit at a similar rate...
  10. pmc Hyperthermia as adjunct to intravesical chemotherapy for bladder cancer
    Richmond A Owusu
    Division of Urology, Duke University Medical Center, Box 2812, Durham, NC 27710, USA
    Biomed Res Int 2013:262313. 2013
    ..This will hopefully allow more widespread use of chemohyperthermia to all bladder cancer patients, including metastatic bladder cancer. ..
  11. ncbi request reprint Clinicopathological characteristics and outcomes of surgically excised renal masses in African Americans
    Peter Qi
    Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC
    Urol Oncol 32:555-60. 2014
    ..In the present study, we report on the clinical and pathological characteristics of African American (AA) patients with surgically excised renal masses and assess the associations between race and oncological outcomes...
  12. ncbi request reprint Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy
    Matvey Tsivian
    Department of Surgery, Duke University Medical Center, Durham, NC, USA
    Urology 82:166-70. 2013
    ..To assess the complications and erectile and urinary functional outcomes of transperineal template mapping biopsy (TTMB) of the prostate...
  13. doi request reprint Clinical performance and utility of a DNA methylation urine test for bladder cancer
    Michael R Abern
    Division of Urology, Duke University Medical Center, Durham, NC Electronic address
    Urol Oncol 32:51.e21-6. 2014
    ..We sought to externally validate a urine-based methylation assay combining TWIST1 and NID2 and assess its clinical utility...